Cision PR Newswire

/C O R R E C T I O N – Jin Jiang Hotels (Malaysia)/

In the news release, JIN JIANG HOTELS (MALAYSIA) TO INTRODUCE SOUTHEAST ASIA'S FIRST RENJOY HOTEL IN DESAR, issued 30-Oct-2026 by Jin Jiang Hotels (Malaysia) over PR Newswire, we are advised by the company that the original version contained incorrect spelling introduced by PR Newswire during transmission. The complete, corrected...

Ractigen Therapeutics Presents Positive Phase I Data for RAG-17 in SOD1-ALS at the 2026 AAN Annual Meeting, Demonstrating 81% Reduction in Neurofilament Light Chain

— Single intrathecal dose of SCAD-siRNA therapeutic RAG-17 yields favorable safety profile and profound, durable biomarker reductions —— Preliminary data from 180 mg cohort...

Alvarez & Marsal Expands Asia-Pacific Presence with Korea Restructuring Practice Launch

SEOUL, South Korea, April 22, 2026 /PRNewswire/ -- Leading global professional services firm Alvarez & Marsal (A&M) today launched a dedicated restructuring practice in...

THE MINISTRY OF DEFENCE ENHANCES NATIONAL RESILIENCE THROUGH SMART DEFENCE TECHNOLOGY INNOVATION

KUALA LUMPUR, Malaysia, April 22, 2026 /PRNewswire/ -- On April 20, The Prime Minister of Malaysia, YAB Dato' Seri Anwar bin Ibrahim, officiated the Defence...

Dawn Medical Technologies Acquires Controlling Interest in Pinnacle Health in Vietnam

Strategic entry into high-growth Vietnam market Combines Dawn's product sourcing capabilities with Pinnacle Health's established local presence and market...

Case Report of Mabwell’s Nectin-4 targeting ADC (9MW2821) in Cervical Cancer Published in The New England Journal of Medicine

SHANGHAI, April 22, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industrial chain, announced that a recent clinical case...

Innovent to Present New Clinical Data of IBI363(PD-1/IL-2α-biased bispecific fusion protein) at the 2026 ASCO Annual Meeting

SAN FRANCISCO and SUZHOU, China, April 22, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and...